Personal tools
You are here: Home → Vaccine Banks Network → Publications
Log in


Forgot your password?
New user?
 

Publications

List of publications relating to VACCINE BANKS

 Publication

 Abstract

PubMed ID/Link
Barnett P.V. and Doel T.R. (1992) Stability and Potency Studies with FMD Vaccines Prepared from Antigens Stored in the Pirbright Bank: Comparisons between Oil and Al(OH Formulations. Report of the Research Group of the Standing Technical Committee of the European Commission for the Control of Foot-and-Mouth Disease, Berne (1992).    pdf
Doel T.R., Williams L. and Barnett P.V. (1994). Emergency vaccination against Foot-and-mouth disease: Rate of development of immunity and its implications for the carrier state. Vaccine 12, 592-600. pdf  8085375
Salt J.S., Williams L., Statham R. and Barnett P.V. (1995). Further Studies on the Rate of Development of Protection in Cattle Given Emergency Vaccination Against FMD. Report, Session of the Research Group of the Standing Technical Committee of the European Commission for the Control of Foot-and-Mouth Disease and the Foot-and-Mouth Disease Subgroup of the Scientific Veterinary Committee of the Commission of the European Community, Moeldling, (1995), Appendix 17 90-97.  pdf
Barnett P.V., Pullen L., Williams L. and Doel T.R. (1996). International Bank for Foot-and-mouth Disease Vaccine: Assessment of Montanide ISA 25 and ISA 206, Two commercially available oil adjuvants. Vaccine 14, 1187-1198.  pdf  8961504
Barnett P., Pullen L., Statham R. and Salt J. (1997). Preliminary Studies on 'Emergency' Foot-and-Mouth Disease Vaccines Formulated with Metabolizable or Semi-metabolizable Oil Adjuvants. Report, Session of the Research Group of the Standing Technical Committee of the European Commission for the Control of Foot-and-Mouth Disease and the Foot-and-Mouth Disease Subgroup of the Scientific Veterinary Committee of the Commission of the European Community, Israel (1997), Appendix 22, 156-161.    pdf
Salt J.S., Dani P., Williams L. and Barnett P. (1997). Efficacy Studies in Pigs with Two Novel Oil-adjuvanted 'Emergency' FMD Vaccines. Report, Session of the Research Group of the Standing Technical Committee of the European Commission for the Control of Foot-and-Mouth Disease and the Foot-and-Mouth Disease Subgroup of the Scientific Veterinary Committee of the Commission of the European Community, Israel (1997), Appendix 23, 162-169.    pdf
Salt J.S., Barnett P.V., Dani P. and Williams L. (1998). Emergency vaccination of pigs against Foot-and-mouth disease: Protection against disease and reduction in contact transmission. Vaccine 16, 746-754.  pdf  9562696
S. J. Cox, P. Dani, J. S. Salt and P. V. Barnett. (1998). Effect of Emergency Vaccines on Local Virus Replication and Virus Persistence in Sheep using Two Different Adjuvant Formulations. Report, Session of the Research Group of the Standing Technical Committee of the European Commission for the Control of Foot-and-Mouth Disease and the Foot-and-Mouth Disease Subgroup of the Scientific Veterinary Committee of the Commission of the European Community, United Kingdom (1998), Appendix 17 , pages 139-143.    pdf
Barnett P.V., Cox S.J. and Salt J.S. (1998). Local and systemic isotype-specific antibody responses to emergency FMD vaccines administered conventionally or by a novel route. Report, Session of the Research Group of the Standing Technical Committee of the European Commission for the Control of Foot-and-Mouth Disease and the Foot-and-Mouth Disease Subgroup of the Scientific Veterinary Committee of the Commission of the European Community, United Kingdom (1998), Appendix 27, pages 201-207.    pdf
Barnett P.V., Pullen L., Warder P. and Statham R. (1998). International Bank for Foot-and-mouth disease vaccine: Preliminary studies on ‘Emergency’ Foot-and-mouth disease vaccines formulated with Montanide IMS (IMMUNOSOL), a new concept in oil adjuvancy. Report, Session of the Research Group of the Standing Technical Committee of the European Commission for the Control of Foot-and-Mouth Disease and the Foot-and-Mouth Disease Subgroup of the Scientific Veterinary Committee of the Commission of the European Community, United Kingdom (1998), Appendix 37 , pages 268-271.    pdf
Barnett P.V. and Statham R.J. (1998). Long Term Stability and Potency of Antigen Concentrates Held by the International Vaccine Bank. Report, Session of the Research Group of the Standing Technical Committee of the European Commission for the Control of Foot-and-Mouth Disease and the Foot-and-Mouth Disease Subgroup of the Scientific Veterinary Committee of the Commission of the European Community, United Kingdom (1998), Appendix 38 , pages 272-275.  pdf  pdf
Cox S.J., Barnett P.V., Dani P. and Salt J.S. (1999). Emergency vaccination of sheep against Foot-and-mouth disease: Protection against disease and reduction in contact transmission. Vaccine 17, 1858-1868.  pdf  10217583
Barnett P.V. and Cox S.J. (1999). The role of small ruminants in the epidemiology and transmission of foot-and-mouth disease. Veterinary Journal 158, 6-13.  pdf  10409411
Barnett P.V., Statham R.J. and Kitching R. P. (1999). Implementation of emergency FMD vaccines: Does current knowledge support the use of suppressive vaccination? Report, Closed Session of the Research Group of the Standing Technical Committee of the European Commission for the Control of Foot-and-Mouth Disease and the Foot-and-Mouth Disease Subgroup of the Scientific Veterinary Committee of the Commission of the European Community, France Paris (1999).    pdf
S. J. Cox and P.V. Barnett. (2000). Longevity of the antibody response in pigs and sheep following a single administration of high potency emergency FMD vaccines. Report, Session of the Research Group of the Standing Technical Committee of the European Commission for the Control of Foot-and-Mouth Disease and the Foot-and-Mouth Disease Subgroup of the Scientific Veterinary Committee of the Commission of the European Community, Borovets, Bulgaria (2000). Appendix 31, 247-254.  pdf  link
Barnett P.V. (2000). The International Foot-and-Mouth Disease Vaccine Bank: An Historical Perspective and its Future Role. Paper presented at XXI World Buiatrics Congress, Punta del Este, Uruguay, 4-8 December 2000.    pdf
Barnett P.V. (2001). Report on the production of emergency O1 Manisa foot-and-mouth disease vaccine for the United Kingdom by the International Vaccine Bank (IVB) 22nd March – 4th April 2001. Published in the Report of the European Commission for the Control of Foot-and-Mouth Disease, Session of the Research Group of the Standing Technical Committee. Island of Moen, Denmark, 12-15 September 2001 Rome 2001, pages 60-63.  pdf  link
Barnett P.V. and Statham R.J. (2001). Stratified and cryogenically stored SACS vaccine, a novel formulating procedure for extending the shelf-life of emergency foot-and-mouth disease vaccines. Published in the Report of the European Commission for the Control of Foot-and-Mouth Disease, Session of the Research Group of the Standing Technical Committee. Island of Moen, Denmark, 12-15 September 2001 Rome 2001, pages 166-172.  pdf  link
Barnett P.V., Samuel A.R. and Statham R.J. (2001). The suitability of the ‘emergency’ foot-and-mouth disease antigens held by the International Vaccine Bank within a global context. Vaccine 19, 2107-2117.  pdf  11228383
Barnett, P.V, Cox S.J., Aggarwal N., Gerber H. and McCullough K.C. (2002). Further studies on the early protective responses of pigs following immunisation with high potency foot-and-mouth disease vaccine. Vaccine 20, 3197-3208.  pdf  12163272
Barnett P.V. and Statham R.J. (2002). Stratified and cryogenically stored (SACS) vaccines, a new concept in emergency foot-and-mouth disease vaccine formulation and storage. Vaccine 20, 2060-2064.  pdf  11972974
Barnett P.V. and Carabin H. (2002). A review of emergency foot-and-mouth disease (FMD) vaccines. Vaccine: 20, 1505-1514.  pdf  11858856
Barnett P., Garland A.J.M., Kitching R.P. and Schermbrucker C.G. (2002). Aspects of emergency vaccination against foot-and-mouth disease. Comparative Immunology, Microbiology & Infectious Diseases 25, 345-364.  pdf  12365810
Cox S.J., Aggarwal N., Statham R.J. and Barnett P.V. (2003). Longevity of antibody and cytokine responses following vaccination with high potency emergency FMD vaccines. Vaccine 21, 1336-1347.  pdf  12615428
Rigden R.C., Carrasco C.P., Barnett P.V., Summerfield A. and McCullough K.C. (2003). Innate immune responses following emergency vaccination against foot-and-mouth disease virus in pigs. Vaccine 21, 1466-1477.  pdf  12615443
Barnett P.V., Statham R.J., Vosloo W. and Haydon D.T. (2003). Foot-and-mouth disease vaccine potency testing: Determination and statistical validation of a model using a serological approach. Vaccine 21, 3240-3248.  pdf  12804854
Murray J.G., Butler R. and Svarcas P.L. (2003). Foot-and-mouth disease emergency preparedness strategy and evaluation: the Australian perspective, in Dodet B., Vicari M. (Eds), Foot-and-mouth disease: control strategies, Elsevier, Paris, 2003, pp 105-113.  pdf
Barnett P.V., Keel P., Reid S., Armstrong R.M., Statham R.J., Voyce C., Aggarwal N. and Cox S.J. (2004). Evidence that high potency foot-and-mouth disease vaccine inhibits local virus replication and prevents the 'carrier' state in sheep. Vaccine 22, 1221-1232.  pdf  15003651
Eblé P.L., Bouma A., de Bruin M.G.M., van Hemert-Kluitenberg F. Van Oirschot J.T. and Dekker A. (2004). Vaccination of pigs two weeks before infection significantly reduces transmission of foot-and-mouth disease virus, Vaccine 22, 1372-1374.  pdf  15063559
Barnard A.L., Arriens A., Cox S., Barnett P., Kristensen B., Summerfield A. and McCullough K.C. (2005). Immune response characteristics following emergency vaccination of pigs against foot-and-mouth disease. Vaccine 23, 1037-1047.  pdf  15620477
Cox S., Voyce C., Parida S., Reid S., Hamblin P., Hutchings G., Paton D. and Barnett P. (2004). Emergency FMD vaccine: Effect of antigen payload on protection, sub-clinical infection and persistence following direct contact challenge of cattle. Report of the session of the Research Group of the Standing Technical Committee on Control of Foot-and-Mouth Disease Crete 2004; pp238-245.  pdf  link
Cox S.J., Voyce C., Parida S., Reid S.M., Hamblin P.A., Paton D.J. and Barnett P.V. (2005). Protection against direct-contact challenge following emergency FMD vaccination of cattle and the effect on virus excretion from the oropharynx. Vaccine 23, 1106-1113.  pdf  15629353
Orsel K., Dekker A., Bouma A., Stegeman J.A. and de Jong M.C.M. (2005). Vaccination against foot and mouth disease reduces virus transmission in groups of calves. Vaccine 23, 4887-4894.  pdf  16002192
Eblé P.L., de Bruin M.G.M., Bouma A., van Hemert-Kluitenberg F. Van Oirschot J.T. and Dekker A. (2006). Comparison of immune responses after intra-typic heterologous and homologous vaccination against foot-and-mouth disease virus in pigs, Vaccine 24, 1274-1281.  pdf  16289709
Cox S.J., Voyce C., Parida S., Reid S.M., Hamblin P.A., Hutchings G., Paton D.J. and Barnett P.V. (2006). Effect of emergency FMD vaccine antigen payload on protection, sub-clinical infection and persistence following direct contact challenge of cattle. Vaccine 24, 3184-3190.  pdf  16488060
Paton D.J., de Clercq K., Greiner M., Dekker A., Brocchi E., Bergmann I., Sammin D.J., Gubbins S. and Parida S. (2006). Application of non-structural protein antibody tests in substantiating freedom from foot-and-mouth disease virus infection after emergency vaccination of cattle, Vaccine 24, 6503-6512.  pdf  16872727
Cox S.J., Voyce C., Parida S., Reid S.M., Hamblin P.A., Hutchings G., Paton D.J. and Barnett P.V. (2006). Further evaluation of higher potency FMD vaccines for emergency use in cattle. Report of the Session of the Research Group of the Standing Technical Committee on Control of Foot-and-Mouth Disease, Paphos, Cyprus 2006; Appendix 38, pp258-266.  pdf  link
Cox S.J., Parida S., Voyce C., Reid S.M., Hamblin P.A., Hutchings G., Paton D.J. and Barnett P.V. (2007). Further evaluation of higher potency vaccines for early protection of cattle against FMDV direct contact challenge. Vaccine 25, 7687-7695.  pdf  17913309
Dekker A. and Barnett P. (2007). Minimum size of antigen stocks in the EU vaccine bank. Report of the 37th Session of the European Commission for the Control of Foot and Mouth Disease. Food and Agriculture organisation of the United Nations, Rome, Italy. 18th-20th April 2007. Appendix 24; pp183-187.    link
Orsel K., de Jong M.C.M., Bouma A., Stegeman J.A. and Dekker A. (2007). Foot and mouth disease virus transmission among vaccinated pigs after exposure to virus shedding pigs, Vaccine 25, 6381-6391.  pdf  17658199
Orsel K., de Jong M.C.M., Bouma A., Stegeman J.A. and Dekker A. (2007). The effect of vaccination on foot and mouth disease virus transmission among dairy cows, Vaccine 25, 327-335.  pdf  16949184
Orsel K., Dekker A., Bouma A., Stegeman J.A. and de Jong M.C.M. (2007). Quantification of foot and mouth disease virus excretion and transmission within groups of lambs with and without vaccination, Vaccine 25, 2673-2679.  pdf  17254674
Eblé P.L., Bouma A., Weerdmeester J.A., Stegeman J.A. and Dekker A. (2007). Serological and mucosal immune responses after vaccination and infection with FMDV in pigs, Vaccine 25, 1043-1054.  pdf  17157418
De Clercq K. , GorisN. , Barnett P.V. and Mackay D.K. (2008). FMD Vaccines: Reflections on Quality aspects for applicability in European disease control policy. Transboundary and Emerging Diseases 55, 46-56.  pdf  18397508
De Clercq K., Goris N., Barnett P.V. and Mackay D.K. (2008). The importance of Quality Assurance/Quality Control of diagnostics to increase the confidence in global Foot-and-mouth disease control. Transboundary and Emerging Diseases 55, 35-45.  pdf  18397507
Cox S., Parida S., Hamblin P., Bankowski B., Carr V., Paton D. and Barnett (2008). Longevity of protection following vaccination with high potency FMD vaccines in cattle – preliminary results. Report of the Session of the Research Group of the Standing Technical Committee on Control of Foot-and-Mouth Disease, Erice 2008, Appendix 15.  pdf link
Brehm K.E., Kumar N., Thulke H.-H. and Haas B. (2008). High potency vaccines induce protection against heterologous challenge with foot-and-mouth disease virus. Vaccine 26, 1681-1687.  pdf  18313814
Parida S., Fleming L., Oh Y., Mahapatra M., Hamblin P., Gloster J. and Paton D.J. (2008). Emergency vaccination of sheep against foot-and-mouth disease: significance and detection of subsequent sub-clinical infection. Vaccine 26, 3469-3479.  pdf  18513836
Eblé P.L., de Koeijer A.A., de jong M.C.M., Engel B. and Dekker A. (2008). A meta-analysis quantifying transmission parameters of FMDV strain O Taiwan among non-vaccinated and vaccinated pigs, Preventive Veterinary Medicine 83, 98-106.  pdf  17683815
Cox S.J. and Barnett P.V. (2009). Experimental evaluation of foot-and-mouth disease vaccines for emergency use in ruminants and pigs: a review Veterinary Research 40, 13. DOI: 10.1051/vetres:2008051  pdf  19040829

 

Document Actions